USANA Health Sciences Inc (USNA)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NYSE
Market Cap: $244.79M
Last updated: Nov 17, 2026 at 11:06 AM ET
USANA Health Sciences Inc (USNA) Stock Forecast
Analysts expect USANA Health Sciences (USNA) to earn $0.55 per share in the fiscal year ending Dec 31, 2026, on revenue of $899.08M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.25.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 127.3% and revenue estimates rise 2.0%.
- Fiscal year ending Dec 31, 2026
- $0.55
- EPS consensus, revenue $899.08M
- Fiscal year ending Dec 31, 2027
- $1.25
- EPS consensus, revenue $916.90M
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.55 | $0.55 to $0.55 | 1 | $899.08M | $899.08M to $899.08M | 1 |
| Dec 31, 2027 | $1.25 | $1.25 to $1.25 | 1 | $916.90M | $916.90M to $916.90M | 1 |
Quarterly Estimates
The EPS consensus rises from $0.12 for the quarter ending Dec 31, 2026 to $0.24 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.12 | $0.12 to $0.13 | 3 | $224.10M | $215.31M to $230.69M | 3 |
| Mar 31, 2027 | $0.24 | $0.24 to $0.24 | 1 | $245.80M | $245.80M to $245.80M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 27.6% from $0.76.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.55 | $0.76 | $0.76 | $0.76 | $0.76 | -27.6% |
| Fiscal year ending Dec 31, 2027 | $1.25 | $1.77 | $1.77 | $1.77 | $1.77 | -29.4% |
| Quarter ending Mar 31, 2027 | $0.24 | $0.34 | $0.34 | $0.34 | $0.34 | -29.4% |
Frequently Asked Questions About USNA
What is the USNA stock forecast?
Consensus analyst estimates put USANA Health Sciences's EPS at $0.55 for the fiscal year ending Dec 31, 2026, on revenue of $899.08M.
What EPS do analysts expect from USNA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.55, with estimates from $0.55 to $0.55 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.25, with estimates from $1.25 to $1.25 from 1 analyst.
What revenue do analysts expect from USANA Health Sciences next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $899.08M, with estimates from $899.08M to $899.08M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $916.90M, with estimates from $916.90M to $916.90M.
How many analysts cover USNA?
1 analyst estimates EPS for USANA Health Sciences for the fiscal year ending Dec 31, 2026.
USNA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors